Abiopharma

🔍 Issa Mohamed Khairie (Executive)

Company: INCYTE CORP (INCY)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Sold 8,264 shares of Common Stock at $106.66 per share (Direct)
  Date: 2026-01-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 76,988.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,856 shares of Common Stock at $109.07 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 66,132.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
• F2: This includes an aggregate of 66,132 shares of common stock issuable pursuant to previously reported RSUs that have not vested.